Prevalence of Parvovirus B19 Viremia Among German Blood Donations and the Relationship to ABO and Rhesus Blood Group Antigens

被引:4
|
作者
Healy, Katie [1 ,2 ]
Aulin, Linda B. S. [3 ,4 ]
Freij, Urban [5 ]
Ellerstad, Marie [5 ]
Brueckle, Lena [6 ]
Hillmering, Helen [5 ]
Svae, Tor-Einar [7 ]
Broliden, Kristina [8 ]
Gustafsson, Rasmus [5 ,9 ]
机构
[1] Karolinska Inst, Dept Dent Med, Div Clin Diagnost & Surg, Stockholm, Sweden
[2] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden
[3] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands
[4] Free Univ Berlin, Clin Pharm & Biochem, Berlin, Germany
[5] Octapharma AB, S-11251 Stockholm, Sweden
[6] Octapharma Plasma GmbH, Langenfeld, Germany
[7] Octapharma Handelsges MbH, Vienna, Austria
[8] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Med Solna,Div Infect Dis, Stockholm, Sweden
[9] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Stockholm, Sweden
来源
JOURNAL OF INFECTIOUS DISEASES | 2023年 / 227卷 / 10期
关键词
ABO; b19V; blood donations; blood group; rhesus; ERYTHROCYTE-P-ANTIGEN; INFECTION; RECEPTOR;
D O I
10.1093/infdis/jiac456
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Parvovirus B19 can be transmitted via asymptomatic blood donations. In 167 123 donations from Germany screened between 2015-2018 we found 22 positives (0.013%). All infected were from rhesus D-antigen-positive donations, suggesting a protective factor in donors lacking this antigen. Background Asymptomatic blood donors can transmit human parvovirus B19 (B19V). Methods We assessed the B19V prevalence among a large cohort of blood donations collected in Germany during 2015-2018. Results In total, 167 123 donations were screened for B19V deoxyribonucleic acid with 22 cases of viremia identified (0.013% positive). Infections peaked at a 4-year interval and the highest number of cases occurred in the summer months. All 22 infections were found in rhesus D-antigen-positive donations, suggesting a protective factor in donors who lack this antigen. Conclusions These findings contribute to our understanding of risk factors for B19V infection among central European blood and plasma donors.
引用
收藏
页码:1214 / 1218
页数:5
相关论文
共 50 条
  • [1] SCREENING BLOOD DONATIONS FOR PARVOVIRUS B19
    COHEN, B
    MILLAR, A
    SCHWIND, P
    LANCET, 1995, 346 (8990): : 1631 - 1631
  • [2] Parvovirus B19 Genotype 2 in blood donations
    Eis-Huebinger, Anna Maria
    Reber, Ulrike
    Edelmann, Anke
    Kalus, Ulrich
    Hofmann, Joerg
    TRANSFUSION, 2014, 54 (06) : 1682 - 1684
  • [3] Parvovirus B19 and HAV screening of whole blood donations
    Stramer, SL
    Dodd, RY
    Smith, RI
    TRANSFUSION, 2001, 41 (09) : 28S - 28S
  • [4] Prevalence of active human parvovirus B19 infection among Brazilian blood donors
    Lisboa, CP
    SaezAlquezar, A
    Chamone, DF
    Durigon, EL
    TRANSFUSION, 1996, 36 (09) : S139 - S139
  • [5] Blood products and parvovirus B19
    Groeneveld, K
    van der Noordaa, J
    NETHERLANDS JOURNAL OF MEDICINE, 2003, 61 (05): : 154 - 156
  • [6] PARVOVIRUS B19 AND BLOOD PRODUCTS
    PROWSE, CV
    LANCET, 1994, 343 (8905): : 1101 - 1101
  • [7] Prevalence and Quantity of Parvovirus B19 DNA Among Blood Donors from a Regional Blood Center in Turkey
    Guclu, Aylin Uskudar
    Yilmaz, Soner
    Baysallar, Mehmet
    Avci, Ismail Yasar
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (04)
  • [8] Congenital Parvovirus B19 Infection: Persistent Viremia and Red Blood Cell Aplasia
    Nadimpalli, Sruti S.
    Miller, Russell S.
    Kamath, Vasudeva M.
    Farkouh, Christiana R.
    Nhan-Chang, Chia-Ling
    Rathe, Jennifer A.
    Collins, Amelie
    Duchon, Jennifer M.
    Neu, Natalie
    Simpson, Lynn L.
    Ratner, Adam J.
    OPEN FORUM INFECTIOUS DISEASES, 2015, 2 (02):
  • [9] Long persistance of parvovirus B19 viremia in blood donors after acute infection
    Hitzler, WE
    Runkel, S
    TRANSFUSION, 2001, 41 (09) : 28S - 29S
  • [10] Relationship between ABO, Rhesus and Kell blood group antigens and gallstone prevalence.: A sonographic survey on 1030 blood donors
    Kratzer, W
    de Lazzer, K
    Wiesneth, M
    Muche, R
    Kächele, V
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (19) : 579 - 583